Article Details

HBM Considers $1.7 Billion Sale of Swixx Biopharma - SWI swissinfo.ch

Retrieved on: 2025-02-20 22:26:43

Tags for this article:

Click the tags to see associated articles and topics

HBM Considers $1.7 Billion Sale of Swixx Biopharma - SWI swissinfo.ch. View article details on hiswai:

Excerpt

(Bloomberg) — HBM Healthcare Investments AG is exploring options for portfolio company Swixx Biopharma SA, including a potential sale that could ...

Article found on: www.swissinfo.ch

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo